🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the safety and immunogenicity of the BPZE1 live attenu...
Status
Completed
Location
Rapid medical Research Inc
Start Date
2019-06-15
Trial ID
NCT03942406
Treatments Being Tested
Infection with human papillomavirus (HPV) has been clearly established as t...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02-13
Trial ID
NCT00426361
Treatments Being Tested
The purpose of the present study is to demonstrate that the changes in the ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-01-05
Trial ID
NCT00808444
This phase 3b study will compare the immunogenicity and reactogenicity of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-04-01
Trial ID
NCT00871000
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of repeating...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-01-01
Trial ID
NCT00610168
Treatments Being Tested
The study is being conducted to demonstrate that the vaccine to prevent gas...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00258154
Treatments Being Tested
The purpose of this study is to assess reactogenicity and safety of simulta...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-12-03
Trial ID
NCT01094171
Treatments Being Tested
The purpose of the study is to compare the immunogenicity and safety of a b...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-07-01
Trial ID
NCT01362322
Treatments Being Tested
Infection with human papillomavirus (HPV) has been clearly established as t...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-09-26
Trial ID
NCT00369824
Treatments Being Tested
The purpose of this study is to evaluate the immune response and reactogeni...
Status
Completed
Location
Multiple Locations
Start Date
2000-09
Trial ID
NCT00879827
Treatments Being Tested